TNF and COVID-19: Furthermore, the production of TNF-a is significantly increased in the CD56Bright NK cells of COVID-19 patients with a severe form (WT-S) at the two time-points (Pt1 and Pt2) compared to healthy donors (Supplementary Figure 5).